Comparing Remimazolam and Midazolam for Sedation in Critically Ill Patients on Ventilators
Official title: Effect of Remimazolam With Protocolized Sedation on Critical Ill, Mechanical Ventilated Patients Compared With Midazolam - A Parallel, Multicenter, Single-blind Randomized Controlled Trial
Run by Zhujiang Hospital · NCT05160987 · Data updated 2026-11-12
This study is testing if a new sedative called remimazolam can help critically ill patients on ventilators spend less time on the machine compared to the standard sedative midazolam.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 440 (estimated) |
| Sponsor | Zhujiang Hospital Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | March 29, 2022 |
| Main results expected | November 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | April 17, 2026 |
| Trial ID | NCT05160987 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are critically ill patients aged 18 to 80 who are mechanically ventilated within the first 48 hours of ICU admission.
✕Probably not a fit
Patients with severe heart conditions, neurological injuries, or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of remimazolam versus midazolam on the duration of mechanical ventilation in critically ill patients. It is a multicenter, single-blind, randomized controlled trial where patients will be assigned to receive either remimazolam or midazolam for sedation. The primary goal is to determine if remimazolam can reduce the time patients spend on mechanical ventilation compared to midazolam. Patients aged 18 to 80 who are mechanically ventilated within 48 hours of ICU admission and expected to stay in the ICU for over 72 hours will be enrolled.
Why it matters
Potential benefit: If successful, this study could lead to improved sedation management and reduced duration of mechanical ventilation for critically ill patients.
How similar studies have gone: Other studies have shown promising results with remimazolam in sedation, suggesting potential benefits, but this specific comparison with midazolam is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Critical ill patients that are mechanically ventilated within the first 48h of admission to the ICU and who would remain in the ICU for over 72h were enrolled in this study. 2. Age 18-80 years. 3. Voluntary informed consent. Exclusion Criteria: 1. Surgical treatment is performed within 24 hours. 2. Craniocerebral injury, post neurosurgery, non drug coma, mental illness or peripheral neuropathy. 3. Heart rates are less than 50 beats / min or severe atrioventricular block without pacemaker support. 4. The mean arterial pressure is less than 55 mmHg even though fluids and vasoactive drugs are administrated. 5. Patients who are known or suspected allergy to benzodiazepines, propofol, dexmedetomidine or opioids. 6. History of alcohol and drug abuse. 7. End stages of lung diseases, such as pulmonary fibrosis, lung damage, etc. 8. Pregnancy.
Where it's running
-
Department of Critical Care Medicine of Zhujiang Hospital,Southern Medical University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Principal investigator: Zhanguo Liu, M.D.PhD — Department of Critical Care Medicine of Zhujiang Hospital
- Study coordinator: Jing Cai
- Email: caijing78@hotmail.com
- Phone: +86-2062782927
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ketamine-Propofol vs Dexmedetomidine-Propofol Sedation for Pediatric Cardiac Catheterization
This study tests two sedative combinations to see which is safer and more effective for children 2–12 undergoing device closure of simple left-to-right heart shunts.
-
Impact of Anesthesia on Inflammation and NETosis During HCC Ablation
This study tests whether a propofol–fentanyl anesthesia plan with lidocaine during radiofrequency ablation for hepatocellular carcinoma affects inflammation and NETosis in patients with small tumors.
-
IR-led deep ketamine sedation for select image-guided procedures
We will try deep ketamine sedation instead of general anesthesia for adults having certain image-guided interventional radiology procedures.
-
Cannabis use and IV sedation during wisdom tooth removal
This project will see if people who use cannabis need different IV sedative doses or have different vital signs and breathing during wisdom tooth removal compared with people who don't use cannabis.
-
Brain‑wave and pain‑signal monitoring during anesthesia for ERCP to map opioid and sedative effects
This trial will test whether continuous brain‑wave (EEG/PSI) and heart‑rate variability (ANI) monitoring during targeted infusions of opioids and sedatives can show how those drugs interact in people having ERCP under general anesthesia.
-
How common pain is in adults on mechanical ventilators in intensive care units
The researchers will measure how often adults on invasive mechanical ventilation in ICUs experience pain and which clinical factors are linked to it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.